UCB SA (UCBJF)
236.94
+1.50
(+0.64%)
USD |
OTCM |
Oct 06, 16:00
UCB Price : 236.94 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 236.94 | 236.94 | 230.50 | 236.94 | 86.00 |
| Oct 05, 2026 | 235.44 | 235.44 | 235.44 | 235.44 | 41.00 |
| Oct 02, 2026 | 238.54 | 238.54 | 238.54 | 238.54 | 17.00 |
| Oct 01, 2026 | 236.90 | 236.90 | 233.44 | 233.44 | 129.00 |
| Sep 30, 2026 | 246.64 | 246.64 | 246.64 | 246.64 | 0.000 |
| Sep 29, 2026 | 247.55 | 247.55 | 246.64 | 246.64 | 74.00 |
| Sep 28, 2026 | 250.59 | 250.59 | 241.48 | 246.11 | 288.00 |
| Sep 25, 2026 | 254.09 | 254.09 | 235.66 | 235.66 | 34.00 |
| Sep 24, 2026 | 230.16 | 248.34 | 230.16 | 243.88 | 543.00 |
| Sep 23, 2026 | 236.49 | 236.49 | 236.49 | 236.49 | 50.00 |
| Sep 22, 2026 | 230.46 | 236.49 | 230.46 | 236.49 | 379.00 |
| Sep 21, 2026 | 233.86 | 252.34 | 233.86 | 233.86 | 429.00 |
| Sep 18, 2026 | 232.56 | 250.52 | 232.56 | 250.52 | 31.00 |
| Sep 17, 2026 | 228.94 | 247.14 | 228.94 | 247.14 | 37.00 |
| Sep 16, 2026 | 249.04 | 249.04 | 247.90 | 248.11 | 121.00 |
| Sep 15, 2026 | 250.59 | 250.59 | 250.59 | 250.59 | 237.00 |
| Sep 14, 2026 | 242.25 | 252.09 | 242.25 | 252.09 | 54.00 |
| Sep 11, 2026 | 250.43 | 250.43 | 246.15 | 246.15 | 272.00 |
| Sep 10, 2026 | 235.10 | 245.56 | 231.00 | 231.75 | 252.00 |
| Sep 09, 2026 | 246.44 | 246.44 | 246.44 | 246.44 | 52.00 |
| Sep 08, 2026 | 251.34 | 251.34 | 246.78 | 251.34 | 279.00 |
| Sep 04, 2026 | 248.40 | 255.34 | 241.56 | 255.34 | 72.00 |
| Sep 03, 2026 | 268.09 | 268.09 | 248.60 | 248.60 | 69.00 |
| Sep 02, 2026 | 264.09 | 264.09 | 244.50 | 264.09 | 389.00 |
| Sep 01, 2026 | 258.46 | 264.74 | 252.16 | 252.16 | 84.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 260.08 |
| Eli Lilly & Co. | 1195.07 |
| Novo Nordisk A/S | 38.16 |
| Pfizer Inc. | 28.10 |
| Teva Pharmaceutical Industries Ltd. | 39.02 |
Price Related Metrics
| PE Ratio | 17.97 |
| PS Ratio | 4.625 |
| PEG Ratio | 0.0201 |
| Price to Free Cash Flow | 32.67 |
| Earnings Yield | 5.57% |
| Market Cap | 45.18B |
| PEGY Ratio | 0.0201 |
| Operating PE Ratio | 14.53 |
| Normalized PE Ratio | 17.81 |